Leukemia, Myelodysplasia, Transplantation
Conference Coverage
Chronic GVHD therapies offer hope for treating refractory disease
Conference Coverage
CXR-Net: An AI-based diagnostic tool for COVID-19
The tool showed promise in a pilot study.
From the Journals
CLL, MBL had lower response rates to flu vaccination, compared with healthy adults
Patients with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis were assessed for their immune response.
Conference Coverage
Asymptomatic screening for COVID-19 in cancer patients still debated
Less than 1% of cancer patients studied were COVID-19 positive on asymptomatic screening.
From the Journals
TBI beats chemoconditioning for ALL transplants in children
Total body irradiation plus etoposide remains the conditioning regimen of choice.
Guidelines
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
Conference Coverage
Model predicts acute kidney injury in cancer patients a month in advance
A machine learning algorithm identified nearly three-quarters of patients who went on to develop acute kidney injury.
Feature
Experts offer roadmap for treating CLL during the pandemic
Perspectives
COVID-19 vaccines and cancer patients: 4 things to know
Conference Coverage
Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapy
Delayed count recovery remains a key safety concern.
Conference Coverage
Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab